Company / Depreciation & Amortization
MBX Biosciences, Inc. Depreciation & Amortization History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$244.0K
FY2024
5-year range
$157.0K / $244.0K
FY2023-FY2024
Trend
+55.4%
vs FY2023
Sector context
#152 of 168
Health Care
What the data says
Among 168 Health Care companies, MBX Biosciences, Inc. is in the top 10% for depreciation & amortization.
Based on SEC 10-K filings.
$244,000 in FY2024.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 168This company $244.0K Sector average $212.9M
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2024, depreciation & amortization increased 55.4% year-over-year.
- Ranks #152 out of 168 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 9.64 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $244.0K | +55.4% |
| FY2023 | $157.0K | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026